At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
SSP-004184AQ +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of SSP-004184AQ (Magnesium Salt) to SSP-004184SS (Disodium Salt) Each Administered as a Single Dose and as Two Doses of SSP-004184 (Free Acid) in Healthy Adult Subjects
In Brief
A Phase 1 clinical trial evaluating SSP-004184AQ and SSP-004184SS for Healthy. Completed, enrolled 28 participants across 1 site.
Detailed Summary
This study will evaluate the relative bioavailability of the new SSP-004184SS capsule formulation compared to the original SSP-004184AQ drug plus excipients formulation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 2013
Enrollment StartAug 2013
Primary CompletionSep 2013
TodayJul 2026
First PostedJul 23, 2013
Enrollment StartAug 5, 2013
Primary CompletionSep 20, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.9 years ago
Interventions
SSP-004184AQdrug
Magnesium salt
SSP-004184SSdrug
Disodium salt